SCHEMBL6238830

SCHEMBL6238830

CCN1CCCC1CN(Cc1ccc(OC)c(Br)c1)c1nc(N)nc(NC2CCCCCC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
PDE5A O76074 1/20 0.41
DRD2 P14416 8/20 0.37
CYP2D6 P10635 3/20 0.36
DRD4 P21917 3/20 0.36
DRD3 P35462 3/20 0.36
ADRA2A P08913 2/20 0.36
CYP2C19 P33261 2/20 0.36
ADRA1A P35348 2/20 0.36
MEN1 O00255 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2C P18825 1/20 0.36
HTR2B P41595 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNH2 Q12809 1/20 0.36
HIF1A Q16665 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
CA2 P00918 2/20 0.35
DRD1 P21728 2/20 0.35
CA9 Q16790 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6235512 0.83 SMN1; SMN2 (0.42) SMN1; SMN2PDE5ADRD2CYP2D6DRD4
SCHEMBL6016946 0.78 SMN1; SMN2 (0.44) SMN1; SMN2PDE5ADRD2CYP2D6DRD4
SCHEMBL4841035 0.77 PDE5A (0.46) PDE5ADRD2CYP2D6DRD4DRD3
SCHEMBL6231918 0.75 DRD2 (0.39) DRD2CYP2D6DRD4DRD3ADRA2A
SCHEMBL6856196 0.75 KDM4E (0.38) SMN1; SMN2DRD2TSHRALDH1A1
SCHEMBL4829473 0.75 DRD2 (0.46) PDE5ADRD2CYP2D6DRD4DRD3
SCHEMBL6229931 0.75 GALR1 (0.42) SMN1; SMN2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL14268377 0.74 DRD2 (0.42) DRD2CYP2D6DRD4DRD3ADRA2A
SCHEMBL5553491 0.73 GALR1 (0.46) DRD2
SCHEMBL5553557 0.72 SMN1; SMN2 (0.37) SMN1; SMN2CYP2D6ADRA2ACYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560817-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS Reddy US Therapeutics, Inc. (US) 2005-08-10 EP claimed
WO-2004026844-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS REDDY US THERAPEUTICS, INC. (US) 2004-04-01 WO claimed